These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17375066)

  • 1. Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease.
    Perrin V; Régulier E; Abbas-Terki T; Hassig R; Brouillet E; Aebischer P; Luthi-Carter R; Déglon N
    Mol Ther; 2007 May; 15(5):903-11. PubMed ID: 17375066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive and selective striatal degeneration in primary neuronal cultures using lentiviral vector coding for a mutant huntingtin fragment.
    Zala D; Benchoua A; Brouillet E; Perrin V; Gaillard MC; Zurn AD; Aebischer P; Déglon N
    Neurobiol Dis; 2005 Dec; 20(3):785-98. PubMed ID: 16006135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early and reversible neuropathology induced by tetracycline-regulated lentiviral overexpression of mutant huntingtin in rat striatum.
    Régulier E; Trottier Y; Perrin V; Aebischer P; Déglon N
    Hum Mol Genet; 2003 Nov; 12(21):2827-36. PubMed ID: 12952868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates.
    Palfi S; Brouillet E; Jarraya B; Bloch J; Jan C; Shin M; Condé F; Li XJ; Aebischer P; Hantraye P; Déglon N
    Mol Ther; 2007 Aug; 15(8):1444-51. PubMed ID: 17505477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter.
    Martin E; Betuing S; Pagès C; Cambon K; Auregan G; Deglon N; Roze E; Caboche J
    Hum Mol Genet; 2011 Jun; 20(12):2422-34. PubMed ID: 21493629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length.
    de Almeida LP; Ross CA; Zala D; Aebischer P; Déglon N
    J Neurosci; 2002 May; 22(9):3473-83. PubMed ID: 11978824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin.
    Benchoua A; Trioulier Y; Zala D; Gaillard MC; Lefort N; Dufour N; Saudou F; Elalouf JM; Hirsch E; Hantraye P; Déglon N; Brouillet E
    Mol Biol Cell; 2006 Apr; 17(4):1652-63. PubMed ID: 16452635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of the JNK pathway in a rat model of Huntington's disease.
    Perrin V; Dufour N; Raoul C; Hassig R; Brouillet E; Aebischer P; Luthi-Carter R; Déglon N
    Exp Neurol; 2009 Jan; 215(1):191-200. PubMed ID: 19022249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent neuroprotection of VEGF₁₆₅ in Huntington's disease striatum.
    Ellison SM; Trabalza A; Tisato V; Pazarentzos E; Lee S; Papadaki V; Goniotaki D; Morgan S; Mirzaei N; Mazarakis ND
    Mol Ther; 2013 Oct; 21(10):1862-75. PubMed ID: 23799534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of gene expression in primary neuron models of Huntington's disease shows that polyglutamine-related effects on the striatal transcriptome may not be dependent on brain circuitry.
    Runne H; Régulier E; Kuhn A; Zala D; Gokce O; Perrin V; Sick B; Aebischer P; Déglon N; Luthi-Carter R
    J Neurosci; 2008 Sep; 28(39):9723-31. PubMed ID: 18815258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease.
    Vacher C; Garcia-Oroz L; Rubinsztein DC
    Hum Mol Genet; 2005 Nov; 14(22):3425-33. PubMed ID: 16204350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a rat model of Huntington's disease based on targeted expression of mutant huntingtin in the forebrain using adeno-associated viral vectors.
    Gabery S; Sajjad MU; Hult S; Soylu R; Kirik D; Petersén Å
    Eur J Neurosci; 2012 Sep; 36(6):2789-800. PubMed ID: 22731249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease.
    Van Raamsdonk JM; Pearson J; Murphy Z; Hayden MR; Leavitt BR
    BMC Neurosci; 2006 Dec; 7():80. PubMed ID: 17147801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion.
    Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S
    J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-dependent effect of BAG1 in ameliorating motor deficits of Huntington disease transgenic mice.
    Orr AL; Huang S; Roberts MA; Reed JC; Li S; Li XJ
    J Biol Chem; 2008 Jun; 283(23):16027-36. PubMed ID: 18400759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration.
    Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B
    J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of heat shock proteins Hsp70 and Hsp27 in cellular protection of the central nervous system.
    Franklin TB; Krueger-Naug AM; Clarke DB; Arrigo AP; Currie RW
    Int J Hyperthermia; 2005 Aug; 21(5):379-92. PubMed ID: 16048836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electroconvulsive shock ameliorates disease processes and extends survival in huntingtin mutant mice.
    Mughal MR; Baharani A; Chigurupati S; Son TG; Chen E; Yang P; Okun E; Arumugam T; Chan SL; Mattson MP
    Hum Mol Genet; 2011 Feb; 20(4):659-69. PubMed ID: 21106706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsp27 overexpression in the R6/2 mouse model of Huntington's disease: chronic neurodegeneration does not induce Hsp27 activation.
    Zourlidou A; Gidalevitz T; Kristiansen M; Landles C; Woodman B; Wells DJ; Latchman DS; de Belleroche J; Tabrizi SJ; Morimoto RI; Bates GP
    Hum Mol Genet; 2007 May; 16(9):1078-90. PubMed ID: 17360721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained effects of nonallele-specific Huntingtin silencing.
    Drouet V; Perrin V; Hassig R; Dufour N; Auregan G; Alves S; Bonvento G; Brouillet E; Luthi-Carter R; Hantraye P; Déglon N
    Ann Neurol; 2009 Mar; 65(3):276-85. PubMed ID: 19334076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.